Market Closed -
Japan Exchange
02:00:00 2024-05-24 am EDT
|
5-day change
|
1st Jan Change
|
1,566
JPY
|
+0.29%
|
|
+3.44%
|
-7.15%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
3,186,231
|
3,105,395
|
3,161,421
|
3,519,738
|
3,381,409
|
2,798,852
|
-
|
-
|
Enterprise Value (EV)
1 |
2,875,157
|
2,777,545
|
2,829,733
|
3,203,752
|
3,004,569
|
2,946,773
|
3,310,867
|
3,219,911
|
P/E ratio
|
14.4
x
|
16
x
|
26.2
x
|
28.5
x
|
34.7
x
|
173
x
|
31.9
x
|
17.4
x
|
Yield
|
2.29%
|
2.39%
|
2.47%
|
2.62%
|
3.19%
|
4.26%
|
4.8%
|
5.11%
|
Capitalization / Revenue
|
2.44
x
|
2.39
x
|
2.53
x
|
2.72
x
|
2.23
x
|
1.84
x
|
1.67
x
|
1.59
x
|
EV / Revenue
|
2.2
x
|
2.14
x
|
2.26
x
|
2.47
x
|
1.98
x
|
1.84
x
|
1.97
x
|
1.83
x
|
EV / EBITDA
|
9.35
x
|
8.95
x
|
13.6
x
|
13.6
x
|
12.6
x
|
16.1
x
|
11.4
x
|
8.48
x
|
EV / FCF
|
12.3
x
|
-16.6
x
|
10.3
x
|
14.1
x
|
10.3
x
|
-5.63
x
|
12.8
x
|
12.8
x
|
FCF Yield
|
8.12%
|
-6.04%
|
9.73%
|
7.08%
|
9.7%
|
-17.8%
|
7.79%
|
7.83%
|
Price to Book
|
2.49
x
|
2.41
x
|
2.28
x
|
2.39
x
|
2.24
x
|
1.85
x
|
1.85
x
|
1.83
x
|
Nbr of stocks (in thousands)
|
1,921,152
|
1,858,405
|
1,857,474
|
1,841,831
|
1,795,756
|
1,792,986
|
-
|
-
|
Reference price
2 |
1,658
|
1,671
|
1,702
|
1,911
|
1,883
|
1,561
|
1,561
|
1,561
|
Announcement Date
|
4/25/19
|
5/14/20
|
4/27/21
|
4/27/22
|
4/27/23
|
4/25/24
|
-
|
-
|
Fiscal Period: Marzo |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,306,348
|
1,300,843
|
1,249,528
|
1,296,163
|
1,518,619
|
1,603,672
|
1,678,253
|
1,757,385
|
EBITDA
1 |
307,370
|
310,387
|
208,703
|
235,370
|
238,767
|
183,358
|
291,406
|
379,851
|
EBIT
1 |
243,912
|
243,991
|
136,051
|
155,686
|
133,029
|
25,518
|
122,854
|
215,829
|
Operating Margin
|
18.67%
|
18.76%
|
10.89%
|
12.01%
|
8.76%
|
1.59%
|
7.32%
|
12.28%
|
Earnings before Tax (EBT)
1 |
248,967
|
245,350
|
145,324
|
156,886
|
132,361
|
24,969
|
119,026
|
212,675
|
Net income
1 |
222,265
|
195,411
|
120,589
|
124,086
|
98,714
|
17,045
|
87,951
|
160,900
|
Net margin
|
17.01%
|
15.02%
|
9.65%
|
9.57%
|
6.5%
|
1.06%
|
5.24%
|
9.16%
|
EPS
2 |
115.0
|
104.2
|
64.93
|
67.08
|
54.24
|
9.510
|
48.92
|
89.72
|
Free Cash Flow
1 |
233,440
|
-167,795
|
275,459
|
226,705
|
291,326
|
-586,348
|
257,890
|
252,139
|
FCF margin
|
17.87%
|
-12.9%
|
22.05%
|
17.49%
|
19.18%
|
-37.3%
|
15.37%
|
14.35%
|
FCF Conversion (EBITDA)
|
75.95%
|
-
|
131.99%
|
96.32%
|
122.01%
|
-
|
88.5%
|
66.38%
|
FCF Conversion (Net income)
|
105.03%
|
-
|
228.43%
|
182.7%
|
295.12%
|
-
|
293.22%
|
156.71%
|
Dividend per Share
2 |
38.00
|
40.00
|
42.00
|
50.00
|
60.00
|
70.00
|
75.00
|
79.79
|
Announcement Date
|
4/25/19
|
5/14/20
|
4/27/21
|
4/27/22
|
4/27/23
|
4/25/24
|
-
|
-
|
Fiscal Period: March |
2020 S1
|
2020 S2
|
2021 S1
|
2021 S2
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2022 S2
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2024 S2
|
2025 Q1
|
2025 Q2
|
2025 S1
|
2025 Q3
|
2025 Q4
|
2025 S2
|
2026 S1
|
2026 S2
|
---|
Net sales
1 |
650,470
|
-
|
615,480
|
-
|
325,523
|
651,666
|
340,627
|
303,870
|
-
|
381,791
|
380,394
|
762,185
|
402,180
|
354,254
|
374,990
|
392,148
|
767,138
|
421,932
|
414,602
|
-
|
411,043
|
426,825
|
800,647
|
454,342
|
392,474
|
-
|
-
|
-
|
EBITDA
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
70,087
|
42
|
-
|
89,100
|
81,600
|
-
|
113,400
|
9,300
|
-
|
-
|
-
|
EBIT
1 |
162,196
|
-
|
86,872
|
-
|
54,079
|
90,169
|
79,202
|
-13,685
|
-
|
33,147
|
86,744
|
119,891
|
61,388
|
-48,250
|
45,794
|
5,222
|
51,016
|
23,103
|
-48,601
|
-
|
36,354
|
44,147
|
83,888
|
62,996
|
-32,022
|
-
|
-
|
-
|
Operating Margin
|
24.94%
|
-
|
14.11%
|
-
|
16.61%
|
13.84%
|
23.25%
|
-4.5%
|
-
|
8.68%
|
22.8%
|
15.73%
|
15.26%
|
-13.62%
|
12.21%
|
1.33%
|
6.65%
|
5.48%
|
-11.72%
|
-
|
8.84%
|
10.34%
|
10.48%
|
13.87%
|
-8.16%
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
161,584
|
-
|
89,091
|
-
|
53,255
|
89,085
|
78,317
|
-10,516
|
-
|
31,679
|
88,801
|
120,480
|
59,758
|
-47,877
|
46,850
|
5,328
|
52,178
|
21,452
|
-48,661
|
-
|
36,318
|
44,696
|
80,888
|
63,561
|
-29,096
|
-
|
-
|
-
|
Net income
1 |
128,527
|
-
|
72,838
|
-
|
40,922
|
71,609
|
60,886
|
-8,409
|
-
|
24,812
|
71,622
|
96,434
|
48,405
|
-46,125
|
33,129
|
-1,459
|
31,670
|
18,653
|
-33,278
|
-
|
27,999
|
34,678
|
59,857
|
49,383
|
-22,479
|
-
|
-
|
-
|
Net margin
|
19.76%
|
-
|
11.83%
|
-
|
12.57%
|
10.99%
|
17.87%
|
-2.77%
|
-
|
6.5%
|
18.83%
|
12.65%
|
12.04%
|
-13.02%
|
8.83%
|
-0.37%
|
4.13%
|
4.42%
|
-8.03%
|
-
|
6.81%
|
8.12%
|
7.48%
|
10.87%
|
-5.73%
|
-
|
-
|
-
|
EPS
2 |
68.16
|
-
|
39.21
|
-
|
22.09
|
38.65
|
32.86
|
-4.430
|
-
|
13.59
|
39.28
|
52.87
|
26.56
|
-25.19
|
18.46
|
-0.8000
|
17.66
|
10.40
|
-18.55
|
-
|
9.885
|
14.12
|
33.40
|
20.20
|
-19.31
|
-
|
-
|
-
|
Dividend per Share
2 |
20.00
|
20.00
|
21.00
|
21.00
|
-
|
25.00
|
-
|
-
|
25.00
|
-
|
-
|
30.00
|
-
|
-
|
-
|
35.00
|
35.00
|
-
|
35.00
|
35.00
|
-
|
-
|
37.00
|
-
|
-
|
37.00
|
39.00
|
39.00
|
Announcement Date
|
10/31/19
|
5/14/20
|
10/30/20
|
4/27/21
|
10/29/21
|
10/29/21
|
2/2/22
|
4/27/22
|
4/27/22
|
8/1/22
|
10/31/22
|
10/31/22
|
2/6/23
|
4/27/23
|
8/1/23
|
11/1/23
|
11/1/23
|
2/5/24
|
4/25/24
|
4/25/24
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
503,449
|
512,015
|
421,059
|
Net Cash position
1 |
311,074
|
327,850
|
331,688
|
315,986
|
376,840
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
1.9
x
|
1.757
x
|
1.108
x
|
Free Cash Flow
1 |
233,440
|
-167,795
|
275,459
|
226,705
|
291,326
|
-586,348
|
257,890
|
252,139
|
ROE (net income / shareholders' equity)
|
17.6%
|
15.3%
|
9%
|
8.7%
|
6.7%
|
1.1%
|
6.48%
|
10.7%
|
ROA (Net income/ Total Assets)
|
13.3%
|
11.6%
|
6.33%
|
6.81%
|
5.53%
|
4.43%
|
4.33%
|
7.07%
|
Assets
1 |
1,676,516
|
1,678,858
|
1,905,121
|
1,821,523
|
1,785,770
|
302,888
|
2,032,490
|
2,276,945
|
Book Value Per Share
2 |
667.0
|
694.0
|
748.0
|
799.0
|
839.0
|
890.0
|
842.0
|
855.0
|
Cash Flow per Share
2 |
148.0
|
140.0
|
104.0
|
110.0
|
112.0
|
97.50
|
175.0
|
182.0
|
Capex
1 |
25,190
|
41,267
|
31,384
|
30,739
|
36,441
|
50,975
|
55,000
|
58,060
|
Capex / Sales
|
1.93%
|
3.17%
|
2.51%
|
2.37%
|
2.4%
|
3.24%
|
3.28%
|
3.3%
|
Announcement Date
|
4/25/19
|
5/14/20
|
4/27/21
|
4/27/22
|
4/27/23
|
4/25/24
|
-
|
-
|
Last Close Price
1,561
JPY Average target price
1,991
JPY Spread / Average Target +27.52% Consensus |
1st Jan change
|
Capi.
|
---|
| -7.15% | 17.82B | | +38.69% | 728B | | +33.26% | 603B | | -4.49% | 360B | | +20.24% | 332B | | +2.12% | 279B | | +15.66% | 244B | | +7.62% | 207B | | -5.40% | 205B | | -0.35% | 163B |
Other Pharmaceuticals
|